Long-term efficacy and safety of deferas
โ
Maria Domenica Cappellini
๐
Article
๐
2008
๐
Elsevier Science
๐
English
โ 117 KB
Deferasirox is an oral iron chelator, with a long half-life, that can be given once daily, because it provides a 24-hour chelation. Several phase II trials and a pivotal phase III trial have established that, in transfusion-dependent patients with beta-thalassaemia major, deferasirox has a similar e